Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Molecular and histologic characteristics of pseudoprogression in diffuse gliomas.

Journal of neuro-oncology - 1 Dec 2016

Lin Andrew L, White Michael, Miller-Thomas Michelle M, Fulton Robert S, Tsien Christina I, Rich Keith M, Schmidt Robert E, Tran David D, Dahiya Sonika

Abstract excerpt

During the 6 month period following chemoradiotherapy, gliomas frequently develop new areas of contrast enhancement, which are due to treatment effect rather than tumor progression. We sought to characterize this phenomenon in oligodendrogliomas (OG) and mixed oligoastrocytomas (MOA). We reviewed the imaging findings from 143 patients with a WHO grade II or III OG or MOA for evidence of pseudoprogression (PsP) or...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Brain Neoplasms
Share to Chromosome Deletion

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Chromosomes, Human, Pair 1

Share to Glioma

Share to Isocitrate Dehydrogenase

Share to Neoplasm Proteins

Share to Neoplasm Recurrence, Local

Share to X-linked Nuclear Protein

Source

Open in PubMed Open full text

Identifiers

PMID: 27704386
DOI: 10.1007/s11060-016-2247-1
PMCID: PMC5518746

Genes

IDH1
ATRX
EGFR

Variants

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Molecular and histologic characteristics of pseudoprogression in diffuse gliomas.PMID 27704386Read ↗

Morphologically, genetically and spatially mixed astrocytoma and oligodendroglioma; chronological acquisition of 1p/19q codeletion and CDKN2A deletion: a case report.Semantic proximity Read ↗

Early and late contrast enhancing lesions after photon radiotherapy for IDH mutated grade 2 diffuse glioma.Semantic proximity Read ↗

Longitudinal assessment of genetic and epigenetic markers in oligodendrogliomas.Semantic proximity Read ↗

Radiogenomics Provides Insights into Gliomas Demonstrating Single-Arm 1p or 19q Deletion.Semantic proximity Read ↗

Prognosis of oligodendroglial tumor with ring enhancement showing central necrotic portion.Semantic proximity Read ↗

H3K27me3 immunostaining is diagnostic and prognostic in diffuse gliomas with oligodendroglial or mixed oligoastrocytic morphology.Semantic proximity Read ↗

ATRX loss refines the classification of anaplastic gliomas and identifies a subgroup of IDH mutant astrocytic tumors with better prognosis.Semantic proximity Read ↗

Specific Genetic Predictors of Chemotherapeutic Response and Survival in Patients With Anaplastic OligodendrogliomasSemantic proximity Read ↗

Clinical and histological characteristics of recurrent oligodendroglial tumors: comparison between primary and recurrent tumors in 18 cases.Semantic proximity Read ↗

Rare dual-genotype IDH mutant glioma: Review of previously reported cases and two new cases of true "oligoastrocytoma".Semantic proximity Read ↗

Oligodendroglial tumors with marked desmoplasia: clinicopathologic and molecular features of 7 cases.Semantic proximity Read ↗

IDH1 mutation as a potential novel biomarker for distinguishing pseudoprogression from true progression in patients with glioblastoma treated with temozolomide and radiotherapy.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.